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Abstract
Metformin (1,1-dimethylbiguanide; MET) is used in the treatment of type 2 diabetes mellitus. MET’s antihyperglycemic
action depends at least in part on its inhibitory effect on hepatic gluconeogenesis. As to gluconeogenesis from amino acids
(e.g. L-alanine), this is associated with an inhibition of L-alanine uptake into hepatocytes. Since this uptake is mediated by an
electrogenic transport mechanism, the aim of the present study was to investigate whether MET has an influence on the liver
cell membrane potential which might explain its inhibitory effect on L-alanine uptake. The experiments were performed in
vivo in anesthetized rats and in vitro using superfused mouse liver slices with the conventional microelectrode technique. In
vivo, MET (160 mg/kg intraperitoneally (i.p.)) significantly depolarized (dV) the liver cell membrane by 6 mV. MET (1 mmol/
l) also depolarized the liver cell membrane in vitro (e.g. 15 min after start of superfusion: dV = 8 mV). MET’s effect was at
least partly reversible. Glucagon (1037 mol/l), which hyperpolarized the liver cell membrane, abolished MET’s effect.
Further, the MET-induced depolarization was completely absent during superfusion with low Cl3 ([Cl3] = 27 mmol/l)
medium, and significantly attenuated by the Cl3 channel blocker NPPB (25 Wmol/l). While MET’s effect was only somewhat
attenuated by blockade of the Na/K/2Cl3 cotransporter or by superfusion with (HCO33 -free) HEPES buffer, the
carboanhydrase blocker acetazolamide (1 mmol/l) or blockade of the HCO33 /Cl
3 exchanger by DIDS (100 Wmol/l), which,
however, also blocks Cl3 channels, abolished its effect. The depolarization of the liver cell membrane by MET was
unaffected by a blockade of K channels with Ba2, a blockade of the Na/K pump or superfusion with low Na medium
([Na] = 26 mmol/l). According to these results, the MET-induced depolarization of the liver cell membrane could be due to
an activation of the Cl3/HCO33 exchanger and thus depend on intracellular HCO
3
3 formation. This activation could then
lead to a disturbance of the equilibrium between intra- and extracellular Cl3 and therefore to an enhanced Cl3 efflux via Cl3
channels. It is plausible that the depolarizing effect induced by MET is associated with its inhibitory effect on
gluconeogenesis by inhibiting uptake of L-alanine and other amino acids into hepatocytes. ß 2001 Elsevier Science B.V. All
rights reserved.
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1. Introduction
The biguanide metformin (1,1-dimethylbiguanide;
MET) is used as an orally active antihyperglycemic
drug in the treatment of human type 2 diabetes mel-
litus [1]. In contrast to another group of orally e¡ec-
tive antidiabetics, the sulfonylureas, which act mainly
by enhancing insulin secretion from pancreatic L cells,
the mechanism of MET’s antihyperglycemic action
remains controversial [2]. While part of MET’s anti-
hyperglycemic e¡ect may depend on reduced intesti-
nal glucose absorption [3], its main action seems to
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be due to improving insulin sensitivity in peripheral
insulin target tissues and suppressing hepatic glucose
output [1,2].
Apart from MET inhibiting hepatic gluconeogen-
esis and hence hepatic glucose output by activation
of pyruvate kinase [4,5], MET also appears to reduce
the supply of gluconeogenic substrates, such as
L-lactate or L-alanine. A recent study suggested that
the inhibitory e¡ect of MET on gluconeogenesis
from L-lactate is secondary to an inhibition of hepat-
ic L-lactate uptake [6], which is mainly mediated by a
carrier-mediated transport system [7,8]. Further, nu-
merous studies suggest that the inhibitory e¡ect of
MET and of other biguanides on hepatic gluconeo-
genesis is also secondary to an inhibition of L-alanine
uptake into liver cells [9^11].
Since this uptake is mediated by an electrogenic
Na-coupled transport mechanism [12^16] and there-
fore depends on the membrane potential, the ¢rst
aim of the present study was to investigate whether
MET a¡ects the hepatic membrane potential. As
the membrane potential was reduced by MET, addi-
tional experiments aimed at clarifying the ionic
mechanisms underlying this e¡ect. Finally, we
wanted to ¢nd out whether MET’s e¡ect on the
liver cell membrane potential is counteracted by
glucagon which has been shown to hyperpolarize liv-
er cells [17,18]. The experiments were performed
under in vivo conditions in anesthetized rats and
under in vitro conditions using superfused mouse
liver slices with the conventional microelectrode
technique.
2. Research design and methods
2.1. In vivo experiments
2.1.1. Animals and maintenance
Adult male Sprague^Dawley rats (OFA; BRL,
Fu«llinsdorf, Switzerland) with an approximate body
weight of 250 g were used for the experiments. Rats
were fed ad libitum with a diet containing 18% fat,
46% carbohydrate and 13% protein [19]. Rats were
adapted to this diet for at least 2 weeks and had ad
libitum access to food and water until the experi-
ment.
2.1.2. Experimental protocol
Rats were injected intraperitoneally (i.p.) with
MET (160 mg/kg (1 mmol/kg)) made up with dis-
tilled water to yield an isotonic solution. Injection
of 0.9% NaCl served as control. Rats were anesthe-
tized with a mixture of ketamine and xylazine ap-
prox. 20 min after the injection. Ten minutes later,
i.e. 30 min after the injection of MET or NaCl, the
liver cell membrane potential was measured in the
left lateral liver lobe as described before [20,21].
Brie£y, the liver was exposed by laparotomy and
¢xed with a nictating forceps after Demarres to pre-
vent movements of the liver lobe due to respiration.
The upper limb of this forceps is open, allowing
puncturing of liver cells by the microelectrode.
Super¢cial liver cells on the parietal surface of the
liver were punctured with the microelectrode to mea-
sure the liver cell membrane potential. The reference
electrode was placed in the abdominal cavity ¢lled
with Krebs^Henseleit solution.
2.2. In vitro experiments
2.2.1. Animals and maintenance
Adult female mice (NMRI; BRL) with a body
weight of 30^50 g were used for the experiments.
Mice were fed the same diet and handled as de-
scribed above for rats.
2.2.2. Liver slice preparation, maintenance and
temperature control
Mice were killed by cervical dislocation and the
median lobe of the liver was removed quickly and
placed on gauze moistened with modi¢ed Krebs^
Henseleit bicarbonate bu¡er (Table 1). The liver
lobe was ¢xed by applying slight pressure with a
glass microscope slide while preparing liver slices
(5U5 mm; thickness about 1 mm) with a scalpel
blade. After incubation in oxygenated (95% O2, 5%
CO2) control bu¡er (Table 1; 37‡C), the liver slices
were placed in an acrylic superfusion chamber with
the encapsulated uncut surface of the liver slice up-
ward. All microelectrode impalements were of super-
¢cial cells on the uncut surface. Viability of this liver
slice preparation has been evaluated previously by
Wondergem and Castillo [22] who measured similar
membrane potentials using superfused mouse liver
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slices or mouse hepatocytes in primary monolayer
culture prepared from whole liver. The liver slices
were superfused at a rate of about 12 ml/min with
oxygenated bu¡er (Table 1).
The composition of the bu¡er solutions used is
shown in Table 1. All bu¡er solutions were equios-
motic. When MET, ouabain or BaCl2 was added to
the solutions, the NaCl concentration was reduced
accordingly (by 0.5 mmol/l or 7.5 mmol/l, respec-
tively). The measured osmolality of the bu¡er solu-
tions was 288 þ 1 mosmol/l.
Part of the experiments were performed with
superfusion solutions with a reduced Na (approx.
26 mmol/l) concentration. In this case, NaCl was
replaced equiosmotically with choline chloride. To
investigate the in£uence of bicarbonate on the depo-
larizing e¡ect of metformin, a bicarbonate-free
superfusion solution bu¡ered with N-[2-hydroxye-
thyl]piperazine-NP-[2-ethanesulfonic acid] (HEPES)
was used. A similar bicarbonate-free bu¡er solution
with a reduced Cl3 (approx. 27 mmol/l) concentra-
tion was also used. NaCl was replaced with sodium
D-gluconate and the concentration of CaCl2 was in-
creased to 10 mmol/l to account for Ca2 chelating
by gluconate. In all experiments, the bu¡er temper-
ature was maintained at 37‡C and monitored contin-
uously with a thermistor (Ebro CTA 1220; Ingold-
stadt, Germany).
2.2.3. Standard experimental protocol
Eight liver slices from at least two mice were used
for each experimental condition. After preparation of
the liver slices, slices were kept in warm oxygenated
control bu¡er until use. After transfer to the super-
fusion chamber, the liver cell membrane potential
was measured after 5 and 10 min. Then, the super-
fusion solutions were switched to the respective ex-
perimental solutions and subsequently, the mem-
brane potential was measured in 3 min intervals.
At each time point, the membrane potential was
measured twice. The mean of these two values was
used for the statistical evaluation of the results (see
below). When the in£uence of various blockers (see
below) on the depolarizing e¡ect of metformin on the
liver cell membrane was investigated, the respective
blocker was added to both the control and the ex-
perimental solutions.
2.3. General procedure
2.3.1. Fabrication of open tip microelectrodes
Open tip microelectrodes were drawn in a horizon-
tal puller (Sachs-Fleming Micropipette Puller PC-84;
Sutter Instrument, San Raphael, CA, USA) from
micro¢lament glass capillaries (1.5 mm o.d., 0.86
mm i.d.; A-M Systems, Everett, WA, USA). Pipettes
were ¢lled with KCl (0.5 mol/l).
2.3.2. Measurement of membrane potential (Vm)
The microelectrode was connected by an Ag-AgCl
half-cell to a high input impedance preampli¢er (1013
6 ; Biologic VF 180; Echirolles, France). For the in
vivo experiments, the reference electrode (Ag-AgCl)
was placed in the abdominal cavity ¢lled with Krebs^
Henseleit solution. In the in vitro setup, the reference
electrode was connected by an Ag-AgCl half-cell to
the tissue chamber by an agar (4% in Krebs^Hense-
leit bu¡er) bridge.
Voltage was measured with a digital voltmeter and
an oscilloscope (Kikusui COS 5020 TM; Kawasaki
Table 1
Composition of the bu¡er solutions used for superfusion of liver slices in the in vitro experimental setup
Krebs^Henseleit bu¡er HCO33 -free HEPES bu¡er Low Na
 bu¡er Low Cl3 HEPES bu¡er
NaCl 118 123 ^ ^
KCl 4.7 4.7 4.7 4.7
CaCl2 2.56 2.56 2.56 10
MgCl2 1.3 1.3 1.3 1.3
NaH2PO4 1.15 1.15 1.15 1.15
NaHCO3 25 ^ 25 ^
Sodium D-gluconate ^ ^ ^ 112.0
HEPES ^ 10 ^ 10
Choline chloride ^ ^ 118 ^
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City, Japan) and recorded on a two-channel recorder
(Rikadenki B-281-L; Kogyo, Japan). Criteria for val-
id micropipette impalements of liver cell were: (1) a
rapid de£ection of the voltage trace on advancing the
microelectrode into the liver slice; (2) a stable voltage
trace within 2 mV for at least 10 s; (3) return of the
voltage trace to within 2 mV of the baseline when the
microelectrode was withdrawn. Resistance of open
tip microelectrodes (20^50 M6) was measured once
before every impalement by passing AC pulses (I = 1
nA; frequency 1000 Hz).
In the in vivo setup, the membrane potential of
¢ve liver cells was measured, and the mean of these
¢ve values was calculated. Only one such mean was
obtained from each animal. The mean coe⁄cient of
variation for the membrane potential measured in
di¡erent cells of a liver lobe was 4.2 þ 0.5%. In the
in vitro experiments, the membrane potential was
measured twice at each time point. The mean of
these two values was used for the statistical evalua-
tion of the results (see below).
2.3.3. Chemicals used
MET, acetazolamide, 5-nitro-2-(3-phenylpropyl-
amino)benzoic acid (NPPB), 4,4P-diisothiocyanatos-
tilbene-2,2P-disulfonic acid (DIDS), bumetanide,
HEPES and ouabain were all from Sigma (Buchs,
Switzerland). Glucagon was from Novo Nordisk
(Ku«snacht, Switzerland), and BaCl2 from Siegfried
(Zo¢ngen, Switzerland).
2.3.4. Statistical evaluation
All values are presented as mean þ standard error
of the mean (x þ S.E.). As mentioned, the membrane
potential of two liver cells was measured at each
individual time point in the in vitro setup. The
mean of these two values was used for the statistical
analysis. Similarly, the membrane potential of ¢ve
liver cells was measured in the in vivo setup in
each rat. The mean of these ¢ve values was then
used for further analysis.
When investigating the time course of the hyper-
polarizing e¡ect of MET or glucagon, repeated
measures ANOVA was used. Di¡erences in the hy-
perpolarizing e¡ect observed under di¡erent condi-
tions, i.e. di¡erences in the membrane potential mea-
sured with the experimental solution compared with
the respective control medium, were evaluated using
the unpaired Student’s t-test, or ANOVA with the
Student^Newman^Keuls post hoc test if more than
two groups were compared. In all cases, a P value
6 0.05 was considered signi¢cant.
3. Results
3.1. In vivo experiments
The membrane potential was measured 30 min
after i.p. injection of MET (160 mg/kg body weight
(1 mmol/kg)) or NaCl solution (control) in anesthe-
tized rats. While the membrane potential measured
under control conditions was similar to that in pre-
vious studies performed under similar conditions
[20,21], MET signi¢cantly depolarized the liver cell
membrane by about 6 mV (Fig. 1).
3.2. In vitro experiments
Under in vitro conditions using superfused mouse
liver slices, MET (0.5 mmol/l, 1 mmol/l) caused a
concentration-dependent depolarization of the liver
cell membrane by 5 mV (dV ; 0.5 mmol/l) and 8 mV
(1 mmol/l ; Fig. 2A). Superfusion with Krebs^Hense-
leit bicarbonate bu¡er which served as control did
not a¡ect the membrane potential over time (Fig.
2A). MET’s e¡ect became signi¢cant after 6^9 min
from the start of superfusion and reached a plateau
after 9 min (Fig. 2A). MET’s e¡ect was at least
Fig. 1. In£uence of MET (160 mg/kg body weight (1 mmol/kg))
injected i.p. on the liver cell membrane potential in anesthetized
rats 30 min after injection. Injection of NaCl solution served as
control. Values are means þ S.E.M. ***Signi¢cant di¡erence be-
tween MET and NaCl (P6 0.001; unpaired Student’s t-test;
n = 6 for all groups).
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partly reversible when switching back to superfusion
with control solution (Fig. 2B).
The depolarizing e¡ect of MET (1 mmol/l) was
completely abolished under low Cl3 conditions
([Cl3] = 27 mmol/l; dV = 1 mV) and signi¢cantly re-
duced when the Cl3 channel blocker NPPB (25
Wmol/l ; dV = 3 mV) was added to the Krebs^Hense-
leit bicarbonate bu¡er (Fig. 3). The blocker of the
Na/K/2Cl3 cotransporter bumetanide (100 Wmol/l
in Krebs^Henseleit bu¡er) somewhat reduced the de-
polarizing e¡ect of metformin (dV = 4 mV; Fig. 3).
As for low Cl3 conditions and NPPB, bumetanide
also reduced the basal membrane potential compared
to normal Cl3, NPPB-free or bumetanide-free con-
ditions (Fig. 3).
While MET’s e¡ect on the liver cell membrane
potential was reduced (dV = 4 mV vs. dV = 8 mV
(P6 0.05) 18 min after the start of superfusion)
when using (bicarbonate-free) HEPES bu¡er instead
of Krebs^Henseleit bicarbonate bu¡er, inhibition of
carboanhydrase by acetazolamide (1 mmol/l in
Krebs^Henseleit bicarbonate bu¡er; dV = 1 mV) or
inhibition of the Cl3/HCO33 exchanger by DIDS
(100 Wmol/l in Krebs^Henseleit bicarbonate bu¡er;
dV = 0 mV), which, however, also blocks Cl3 chan-
nels, abolished its e¡ect (Fig. 4). In contrast, neither
blockade of K channels by Ba2 (5 mmol/l), nor
inhibition of the Na/K-ATPase by ouabain
(1 mmol/l) or use of low Na superfusion bu¡er
Fig. 2. (A) In£uence of MET (0.5 mmol/l, 1 mmol/l) on the liv-
er cell membrane potential of mouse liver slices. Superfusion
with Krebs^Henseleit bicarbonate bu¡er (control) from t =310
min to t = 0 min. Then MET was added. (B) Reversibility of
the depolarizing e¡ect of MET (1 mmol/l). *;***Signi¢cant dif-
ference between metformin and control (*P6 0.05 or
***P6 0.001, respectively; repeated measures ANOVA with the
Student^Newman^Keuls post hoc test; n = 8 for all groups).
Fig. 3. In£uence of superfusion with low Cl3 HEPES bu¡er
([Cl3] = 27 mmol/l), the Cl3 channel blocker NPPB (25 Wmol/l ;
in Krebs^Henseleit bicarbonate bu¡er) or the blocker of the
Na/K/2Cl3 cotransporter bumetanide (100 Wmol/l ; in Krebs^
Henseleit bu¡er) on the depolarizing e¡ect of MET (1 mmol/l)
in mouse liver slices. **;***Signi¢cant di¡erence versus start of
superfusion (t = 0 min; **P6 0.01 or ***P6 0.001, respectively;
repeated measures ANOVA with the Student^Newman^Keuls
post hoc test ; n = 8 for all groups).
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([Na] = 26 mmol/l) a¡ected the depolarization of the
liver cell membrane induced by MET (1 mmol/l ;
Fig. 5).
Finally, while MET (1 mmol/l) depolarized the liv-
er cell membrane and while glucagon (1037 mol/l)
hyperpolarized the liver cell membrane, co-superfu-
sion of MET and glucagon left the membrane poten-
tial unchanged compared to control conditions
(Fig. 6).
4. Discussion
The present study shows that metformin exerts a
depolarizing e¡ect on the liver cell membrane both
under in vivo and in vitro conditions. Under in vitro
conditions, the depolarizing e¡ect of MET was ob-
served at concentrations which are similar to thera-
peutic levels in portal blood (for review, see [23]).
The in vitro experiments further show that MET’s
e¡ect is at least partly reversible and that glucagon
Fig. 4. In£uence of superfusion with HEPES bu¡er, with the
inhibitor of carboanhydrase acetazolamide (1 mmol/l ; in
Krebs^Henseleit bicarbonate bu¡er) or with DIDS (100 Wmol/l ;
in Krebs^Henseleit bicarbonate bu¡er), an inhibitor of the Cl3/
HCO33 exchanger, on the depolarizing e¡ect of MET (1 mmol/
l) in mouse liver slices. ***Signi¢cant di¡erence versus start of
superfusion (t = 0 min; P6 0.001; repeated measures ANOVA
with the Student^Newman^Keuls post hoc test; n = 8 for all
groups).
Fig. 5. In£uence of blockade of K channels by Ba2 (5 mmol/
l), inhibition of the Na/K-ATPase by ouabain (1 mmol/l) or
use of low Na superfusion bu¡er ([Na] = 26 mmol/l) on the
depolarizing e¡ect of MET (1 mmol/l) in mouse liver slices.
*;***Signi¢cant di¡erence versus start of superfusion (t = 0 min;
*P6 0.05 or ***P6 0.001, respectively; repeated measures AN-
OVA with the Student^Newman^Keuls post hoc test ; n = 8 for
all groups).
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antagonized its e¡ect. MET’s depolarizing e¡ect was
absent when liver slices were superfused with low Cl3
bu¡er, and was also absent in the presence of the Cl3
channel blocker NPPB while the blocker of the Na/
K/2Cl3 cotransporter bumetanide had only a minor
in£uence on MET’s depolarizing e¡ect. Further,
MET’s e¡ect was also abolished by blockade of the
carboanhydrase by acetazolamide and of the Cl3/
HCO33 exchanger by DIDS. Since DIDS also blocks
hepatic Cl3 channels [24], its e¡ect might also partly
be due to this action. Finally, MET’s e¡ect was not
in£uenced by BaCl2, by superfusion with low Na
bu¡er or by the inhibitor of the Na/K-ATPase,
ouabain.
The results provide evidence for the depolarizing
e¡ect of MET on the liver cell membrane being
mediated by an enhanced Cl3 e¥ux from liver cells
via Cl3 channels. Further, MET’s e¡ect depends on
intracellular bicarbonate which, probably through
the Cl3/HCO33 exchanger importing Cl
3 in exchange
for HCO33 , is functionally coupled to Cl
3 e¥ux. The
results also provide evidence that MET’s depolariz-
ing e¡ect on the liver cell membrane is independent
of an in£uence on K or Na £uxes, the Na/K/
2Cl3 cotransporter or the function of the Na/K-
ATPase.
Interestingly, the depolarizing e¡ect of MET was
only somewhat reduced when liver slices were super-
fused with nominally bicarbonate-free HEPES bu¡-
er. While at ¢rst sight this indicates that HCO33 is
only of minor importance for this e¡ect, MET’s ef-
fect was completely abolished during superfusion
with Krebs^Henseleit bicarbonate bu¡er containing
the carboanhydrase blocker acetazolamide. This
clearly indicates that MET’s depolarizing e¡ect de-
pends on the intracellular formation of bicarbonate
while extracellular bicarbonate seems to play only a
minor role.
While intracellular and extracellular Cl3 is gener-
ally supposed to distribute passively under steady
state conditions depending on the liver cell mem-
brane potential [25,26], an in£uence on Cl3 £uxes,
e.g. by MET, may a¡ect the liver cell membrane
potential when the steady state equilibrium is dis-
turbed. It is thus plausible that MET, by activating
the Cl3/HCO33 exchanger, disturbs the Cl
3 distribu-
tion across the plasma membrane and thus enhances
Cl3 e¥ux, leading to a depolarization of liver cells.
A functional coupling between Cl3 channels and the
Cl3/HCO33 exchanger has already been described in
other cell types such as pancreatic duct cells [27]. The
exact mechanism how MET a¡ects the Cl3/HCO33
exchanger and Cl3 channels is unknown. Since
MET seems to exert its metabolic e¡ects at least in
part at the cell membrane level by interfering with
membrane £uidity and protein con¢guration [23], it
is plausible that its e¡ects on the liver cell membrane
potential are also caused by in£uencing the Cl3/
HCO33 exchanger and/or Cl
3 channel function at
the cell membrane level. Whether other agents hav-
ing an e¡ect on Cl3 channels also in£uence glucose
production and/or gluconeogenesis is unknown to
the authors.
We observed a lower baseline membrane potential
when liver slices were superfused with HEPES bu¡er
or with low Cl3 HEPES bu¡er than with Krebs^
Henseleit bicarbonate bu¡er. This is in accordance
with previous observations and may perhaps be re-
lated to a decrease in K conductance due to a de-
crease in intracellular pH [28,29].
The baseline membrane potential was also reduced
when liver slices were superfused with Krebs^Hense-
leit bicarbonate bu¡er containing NPPB or bumeta-
nide. While in the case of NPPB this may have been
due to an inhibitory e¡ect of NPPB on K conduc-
tance [30], the mechanism underlying bumetanide’s
e¡ect on the baseline membrane potential is not
clear.
The depolarizing e¡ect of MET on the liver cell
Fig. 6. In£uence of MET (1 mmol/l) and glucagon (1037 mol/l)
on the liver cell membrane potential in superfused mouse liver
slices. *;**;***Signi¢cant di¡erence versus MET+glucagon or
versus control (P6 0.05, P6 0.01 or P6 0.001, respectively;
ANOVA with the Student^Newman^Keuls post hoc test; n = 8
for all groups).
BBAMEM 78121 9-7-01
T.A. Lutz et al. / Biochimica et Biophysica Acta 1513 (2001) 176^184182
membrane may explain its inhibitory e¡ect on L-ala-
nine uptake in liver cells which is thought to be at
least partly responsible for the MET-induced inhibi-
tion of gluconeogenesis and hepatic glucose output
[9^11]. Uptake of L-alanine into liver cells is medi-
ated by an electrogenic Na-coupled transport mech-
anism [12^16] and depolarization of the liver cell
membrane has been shown to reduce amino acid
uptake [22]. Depolarization of the liver cell mem-
brane through MET-stimulated Cl3 e¥ux would re-
duce the driving force for electrogenic Na-coupled
uptake of L-alanine and other gluconeogenic amino
acids, e.g. glutamine [33]. Therefore, the MET-in-
duced depolarization of the liver cell membrane
could be directly responsible for at least part of the
inhibition of gluconeogenesis from L-alanine through
reduced L-alanine uptake into liver cells [9^11].
In this context, it was interesting to note that the
depolarizing e¡ect of metformin, an agent which in-
hibits gluconeogenesis [1,2], was antagonized by glu-
cagon, a pancreatic hormone which stimulates gluco-
neogenesis [31] and hyperpolarizes the liver cell
membrane ([17,32], and present study). This antago-
nism is most likely due to superposition of the e¡ects
of MET and glucagon on the liver cell membrane
potential.
In line with our hypothesis of an inhibition of
L-alanine uptake into hepatocytes due to the depola-
rizing e¡ect of MET on liver cells, the glucagon in-
duced hyperpolarization of liver cells seems to ac-
count for at least part of the increased rate of
L-alanine uptake into liver cells and hence the gluca-
gon stimulated gluconeogenesis from amino acids
[10]. Apart from the antagonistic e¡ects of MET
and glucagon on the uptake of gluconeogenic amino
acids into liver cells and on gluconeogenesis, MET
and glucagon also seem to exert opposite e¡ects on
fat metabolism [1].
Finally, while the control of the hepatic membrane
potential by glucagon has been supposed to be re-
lated to cell volume regulation and cell metabolism
(cell shrinking contributing to increased glycogenol-
ysis, gluconeogenesis and proteolysis; see [18]), it re-
mains to be investigated whether the same also ap-
plies to MET, though with reversed premises.
The clinical relevance of the e¡ect of MET on the
membrane voltage is underlined by the fact that the
depolarizing e¡ect of MET was observed at concen-
trations which are similar to therapeutic levels in
portal blood (for review, see [23]). Because L-alanine
transport is enhanced in diabetes mellitus [34] and
because increased gluconeogenesis is a metabolic
hallmark in diabetes contributing to fasting and
post-prandial hyperglycemia [35], MET could antag-
onize these changes at their very base through its
depolarizing e¡ect on the liver cell membrane, lead-
ing to reduced availability of L-alanine and other
amino acids and thus a reduced rate of gluconeogen-
esis.
Since the uptake of conjugated bile acids into he-
patocytes is mediated by an electrogenic Na-
coupled transport mechanism and thus depends on
the membrane voltage [36], it remains to be investi-
gated whether MET, by depolarizing the liver cell
membrane, also a¡ects bile acid secretion and the
electrogenic transport of other substances.
In summary, we have shown that MET depolarizes
the liver cell membrane under in vivo and in vitro
conditions. This e¡ect appears to be due to Cl3 ef-
£ux from liver cells being coupled to intracellular
bicarbonate and an activation of the Cl3/HCO33 ex-
changer by MET. MET’s depolarizing e¡ect on the
liver cell membrane could directly contribute to re-
duced electrogenic uptake of L-alanine and other
amino acids in liver cells and thus MET’s inhibitory
e¡ect on gluconeogenesis.
References
[1] C.J. Bailey, M.R.C. Path, R.C. Turner, Metformin, New
Engl. J. Med. 334 (1996) 574^579.
[2] G. Perriello, Mechanisms of metformin action in non-insu-
lin-dependent diabetes mellitus, Diabetes Metab. Rev. 11
(1995) S51^S56.
[3] C.J. Bailey, Metformin and intestinal glucose handling, Dia-
betes Metab. Rev. 11 (1995) S23^S32.
[4] D. Argaud, H. Roth, N. Wiernsperger, X.M. Leverve, Met-
formin decreases gluconeogenesis by enhancing the pyruvate
kinase £ux in isolated rat hepatocytes, Eur. J. Biochem. 213
(1993) 1341^1348.
[5] M.F. McCarty, A proposal for the locus of metformin’s
clinical action: potentiation of the activation of pyruvate
kinase by fructose-1,6-diphosphate, Med. Hypotheses 52
(1999) 89^93.
[6] J. Radziuk, Z. Zhang, N. Wiernsperger, S. Pye, E¡ects of
metformin on lactate uptake and gluconeogenesis in the per-
fused rat liver, Diabetes 46 (1997) 1406^1413.
BBAMEM 78121 9-7-01
T.A. Lutz et al. / Biochimica et Biophysica Acta 1513 (2001) 176^184 183
[7] P. Fafournoux, C. Demigne, C. Remesy, Carrier-mediated
uptake of lactate in rat hepatocytes. E¡ects of pH and pos-
sible mechanisms for L-lactate transport, J. Biol. Chem. 260
(1985) 292^299.
[8] V.N. Jackson, A.P. Halestrap, The kinetics, substrate, and
inhibitor speci¢city of the monocarboxylate (lactate) trans-
porter of rat liver cells determined using the £uorescent in-
tracellular pH indicator, 2P,7P-bis(carboxyethyl)-5(6)-car-
boxy£uorescein, J. Biol. Chem. 271 (1996) 861^868.
[9] N. Hotta, T. Komori, M. Kobayashi, F. Sakakibara, N.
Koh, N. Sakamoto, The inhibitory action of buformin, a
biguanide on gluconeogenesis from alanine and its transport
system in rat livers, Diabetes Res. Clin. Pract. 19 (1993) 49^
58.
[10] T. Komori, N. Hotta, M. Kobayashi, F. Sakakibara, N.
Koh, N. Sakamoto, Biguanides may produce hypoglycemic
action in isolated rat hepatocytes through their e¡ects on
L-alanine transport, Diabetes Res. Clin. Pract. 22 (1993)
11^17.
[11] K. Mori, J. Nakamura, N. Koh, F. Sakakibara, Y. Hamada,
T. Hara, T. Komori, E. Nakashima, K. Naruse, N. Take-
uchi, N. Hotta, Increased alanine uptake and lipid synthesis
from alanine in isolated hepatocytes of Wistar-Kyoto fatty
rats: an inhibitory e¡ect of biguanides, Can. J. Physiol.
Pharmacol. 75 (1997) 179^184.
[12] J.M. vanAmerlsvoort, H.J. Sips, K. vanDam, Sodium-de-
pendent alanine transport in plasma-membrane vesicles
from rat liver, Biochem. J. 174 (1978) 1083^1086.
[13] L.O. Kristensen, M. Folke, E¡ects of perturbation of the
Na electrochemical gradient on in£ux and e¥ux of alanine
in isolated rat hepatocytes, Biochim. Biophys. Acta 855
(1986) 49^57.
[14] L.O. Kristensen, Associations between transports of alanine
and cations across cell membrane in rat hepatocytes, Am.
J. Physiol. 251 (1986) G575^G584.
[15] T.W. Simmons, R.H. Moseley, J.L. Boyer, N. Ballatori,
Modulation of Na/alanine cotransport in liver sinusoidal
membrane vesicles by internal divalent cations, Biochim.
Biophys. Acta 1023 (1990) 462^468.
[16] J.G. Fitz, B.F. Scharschmidt, Regulation of transmembrane
electrical potential gradient in rat hepatocytes in situ, Am.
J. Physiol. 252 (1987) G56^G64.
[17] O.H. Petersen, The e¡ect of glucagon on the liver cell mem-
brane potential, J. Physiol. 239 (1974) 647^656.
[18] J. Graf, D. Ha«ussinger, Ion transport in hepatocytes: mech-
anisms and correlations to cell volume, hormone actions and
metabolism, J. Hepatol. 24 (Suppl. 1) (1996) 53^77.
[19] R. Rossi, E. Scharrer, Hyperpolarization of the liver cell
membrane by palmitate as a¡ected by glucose and lactate
^ implications for control of feeding, J. Auton. Nerv. Syst.
56 (1995) 45^49.
[20] T.A. Lutz, S. Boutellier, E. Scharrer, Hyperpolarization of
the rat hepatocyte membrane by 2,5-anhydro-D-mannitol in
vivo, Life Sci. 62 (1998) 1427^1432.
[21] S. Boutellier, T.A. Lutz, M. Volkert, E. Scharrer, 2-Mercap-
toacetate, an inhibitor of fatty acid oxidation, decreases the
membrane potential in rat liver in vivo, Am. J. Physiol. 277
(1999) R301^R305.
[22] R. Wondergem, L.B. Castillo, Quinine decreases hepatocyte
transmembrane potential and inhibits amino acid transport,
Am. J. Physiol. 254 (1988) G795^G801.
[23] N.F. Wiernsperger, Membrane physiology as a basis for the
cellular e¡ects of metformin in insulin resistance and diabe-
tes, Diabetes Metab. 25 (1999) 110^127.
[24] X.-J. Meng, S.A. Weinman, cAMP- and swelling-activated
chloride conductance in rat hepatocytes, Am. J. Physiol. 271
(1996) C112^C120.
[25] K. Wang, R. Wondergem, Hepatocyte water volume and
potassium activity during hypotonic stress, J. Membr. Biol.
135 (1993) 137^144.
[26] K. Wang, R. Wondergem, Redistribution of hepatocyte
chloride during L-alanine uptake, J. Membr. Biol. 135
(1993) 237^244.
[27] M.G. Raeder, The origin of and subcellular mechanisms
causing pancreatic bicarbonate secretion, Gastroenterology
103 (1992) 1674^1684.
[28] J.G. Fitz, T.E. Trouillot, B.F. Scharschmidt, E¡ect of pH on
membrane potential and K conductance in cultured rat he-
patocytes, Am. J. Physiol. 257 (1989) G961^G968.
[29] J.G. Fitz, S.D. Lidofsky, B.F. Scharschmidt, Regulation of
hepatic Na-HCO33 cotransport and pH by membrane po-
tential di¡erence, Am. J. Physiol. 265 (1993) G1^G8.
[30] B. Illek, H. Fischer, K.M. Kreusel, U. Hegel, W. Clauss,
Volume-sensitive basolateral K channels in HT-29/B6 cells :
block by lidocaine, quinidine, NPPB, and Ba2, Am.
J. Physiol. 263 (1992) C674^C683.
[31] A.D. Cherrington, J.L. Chiasson, J.E. Liljenquist, W.W.
Lacy, C.R. Park, Control of hepatic glucose output by glu-
cagon and insulin in the intact dog, Biochem. Soc. Symp. 43
(1978) 31^45.
[32] N. Friedmann, G. Dambach, Antagonistic e¡ect of insulin
on glucagon-evoked hyperpolarization. A correlation be-
tween changes in membrane potential and gluconeogenesis,
Biochim. Biophys. Acta 596 (1980) 180^185.
[33] N. Nurjhan, A. Bucci, G. Perriello, M. Sturmvoll, G. Dailey,
D.M. Bier, I. Toft, T.G. Jenssen, J.E. Gerich, Glutamine: a
major gluconeogenic precursor and vehicle for interorgan
carbon transport in man, J. Clin. Invest. 95 (1995) 272^277.
[34] N.R. Rosenthal, R. Jacob, E. Barrett, Diabetes enhances
activity of alanine transport in liver plasma membrane
vesicles, Am. J. Physiol. 248 (1985) E581^587.
[35] R.J. Unger, L. Orci, The role of glucagon in the endogenous
hyperglycemia of diabetes mellitus, Annu. Rev. Med. 28
(1977) 119^130.
[36] S. Gru«ne, X.-J. Meng, S.A. Weinman, cAMP stimulates
£uorescent bile acid uptake into hepatocytes by membrane
hyperpolarization, Am. J. Physiol. 270 (1996) G339^G346.
BBAMEM 78121 9-7-01
T.A. Lutz et al. / Biochimica et Biophysica Acta 1513 (2001) 176^184184
